About Laurence Marsteller
Form D filings for Radiance Therapeutics from 2018 to 2023 list Laurence Marsteller as chief executive officer and director.
Laurence Marsteller first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Laurence Marsteller in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Laurence Marsteller works with at each company, as listed on that company's latest Form D.
Radiance Therapeutics, Inc. · Form D/A, Jun 29, 2023